Total Payments
$584.93
2024 Payments
$76.24
Companies
17
Transactions
32
Medicare Patients
2,068
Medicare Billing
$153,577
Payment Breakdown by Category
Food & Beverage$571.04 (97.6%)
Education$13.89 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $571.04 | 31 | 97.6% |
| Education | $13.89 | 1 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $96.75 | 6 | $0 (2019) |
| Novo Nordisk Inc | $95.03 | 5 | $0 (2022) |
| UCB, Inc. | $48.07 | 2 | $0 (2024) |
| PFIZER INC. | $46.59 | 3 | $0 (2023) |
| Eisai Inc. | $41.16 | 2 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $36.25 | 2 | $0 (2019) |
| Smith+Nephew, Inc. | $30.24 | 1 | $0 (2023) |
| Gilead Sciences, Inc. | $29.11 | 2 | $0 (2020) |
| Dexcom, Inc. | $28.17 | 1 | $0 (2024) |
| The Medicines Company | $26.16 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $76.24 | 3 | UCB, Inc. ($48.07) |
| 2023 | $48.14 | 2 | Smith+Nephew, Inc. ($30.24) |
| 2022 | $33.30 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($17.23) |
| 2021 | $11.28 | 1 | Genentech USA, Inc. ($11.28) |
| 2020 | $39.36 | 3 | Cardiovascular Systems Inc. ($15.70) |
| 2019 | $118.32 | 7 | Novo Nordisk Inc ($35.96) |
| 2018 | $64.36 | 3 | Novo Nordisk Inc ($43.00) |
| 2017 | $193.93 | 11 | Allergan Inc. ($85.95) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: Endocrinology | ||||||
| 06/15/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Neurology | ||||||
| 04/25/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: Neurology | ||||||
| 12/14/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: VACCINES | ||||||
| 06/27/2023 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: Pharma Products | ||||||
| 07/07/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Cardio-renal | ||||||
| 02/23/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Diabetes | ||||||
| 01/21/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Virology & Specialty Care | ||||||
| 11/24/2020 | Cardiovascular Systems Inc. | Peripheral Orbital Atherectomy System (Device) | Food and Beverage | Cash or cash equivalent | $15.70 | General |
| Category: Atherectomy Device | ||||||
| 03/05/2020 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT (Biological), ADACEL, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Vaccines | ||||||
| 01/02/2020 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: HIV | ||||||
| 11/14/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/08/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: VACCINES | ||||||
| 07/23/2019 | KCI USA, Inc | ACTIVAC (Device), SNAP | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: DEVICES | ||||||
| 06/27/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Diabetes | ||||||
| 05/02/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: DIABETES | ||||||
| 03/11/2019 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: HIV | ||||||
| 02/07/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Diabetes | ||||||
| 11/01/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Diabetes | ||||||
| 09/06/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Diabetes | ||||||
| 06/05/2018 | Abbott Laboratories | FreeStyle Freedom Lite system (Device) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Diabetes Care | ||||||
| 11/15/2017 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/05/2017 | Eisai Inc. | Banzel (Drug) | Food and Beverage | Cash or cash equivalent | $19.73 | General |
| Category: Neurology | ||||||
| 07/27/2017 | Allergan Inc. | NAMZARIC (Drug), NAMENDA XR | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2017 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $21.43 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 383 | 626 | $107,088 | $27,980 |
| 2022 | 10 | 483 | 774 | $134,959 | $40,784 |
| 2021 | 11 | 547 | 823 | $134,928 | $44,632 |
| 2020 | 13 | 655 | 947 | $115,077 | $40,181 |
Total Patients
2,068
Total Services
3,170
Medicare Billing
$153,577
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 132 | 220 | $49,940 | $13,552 | 27.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 32 | 32 | $8,792 | $3,862 | 43.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 61 | $14,678 | $3,778 | 25.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $10,564 | $2,394 | 22.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 38 | 38 | $5,500 | $1,541 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 37 | 44 | $6,776 | $1,428 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 25 | $8,064 | $1,265 | 15.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 16 | $1,314 | $145.74 | 11.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 16 | 160 | $1,460 | $13.76 | 0.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 146 | 263 | $59,701 | $16,390 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 87 | $26,698 | $7,645 | 28.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 40 | 40 | $9,840 | $4,971 | 50.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 58 | 72 | $11,088 | $2,978 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 36 | $8,412 | $2,718 | 32.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 34 | 36 | $5,750 | $1,827 | 31.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $5,436 | $1,673 | 30.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 19 | $4,427 | $1,393 | 31.5% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2022 | 15 | 15 | $1,242 | $991.68 | 79.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 18 | $1,080 | $160.92 | 14.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 11 | 11 | $160.00 | $24.60 | 15.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 17 | 165 | $1,125 | $13.09 | 1.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 176 | 277 | $52,072 | $17,384 | 33.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 66 | 69 | $22,630 | $6,621 | 29.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 32 | 32 | $7,872 | $4,067 | 51.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 40 | $8,730 | $3,236 | 37.1% |
About Dr. Mohammed Sheikh, MD
Dr. Mohammed Sheikh, MD is a Internal Medicine healthcare provider based in Independence, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1144216961.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammed Sheikh, MD has received a total of $584.93 in payments from pharmaceutical and medical device companies, with $76.24 received in 2024. These payments were reported across 32 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($571.04).
As a Medicare-enrolled provider, Sheikh has provided services to 2,068 Medicare beneficiaries, totaling 3,170 services with total Medicare billing of $153,577. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Geriatric Medicine
- Location Independence, LA
- Active Since 09/27/2005
- Last Updated 04/29/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144216961
Products in Payments
- NAMZARIC (Drug) $43.80
- Victoza (Drug) $43.00
- BYSTOLIC (Drug) $42.15
- Ozempic (Drug) $35.96
- COLLAGENASE SANTYL (Drug) $30.24
- Dexcom G6 Transmitter (Medical Supply) $28.17
- Briviact (Drug) $26.21
- ORBACTIV (Drug) $26.16
- SOLIQUA 100/33 (Drug) $22.89
- Rystiggo (Drug) $21.86
- Fycompa (Drug) $21.43
- FreeStyle Freedom Lite system (Device) $21.36
- Banzel (Drug) $19.73
- PREVNAR 20 (Biological) $17.90
- Biktarvy (Drug) $17.49
- Kerendia (Drug) $17.23
- Rybelsus (Drug) $16.07
- ACTIVAC (Device) $15.90
- Peripheral Orbital Atherectomy System (Device) $15.70
- PREVNAR - 13 (Biological) $15.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Independence
Stephen Dickson, M.d, M.D
Internal Medicine — Payments: $85,173
Internal Medicine $85,173
Dr. Jayasheel Eshcol, M.d, M.D
Internal Medicine — Payments: $70,112
Internal Medicine $70,112
Bruce Rogen, Md, MD
Internal Medicine — Payments: $40,043
Internal Medicine $40,043
Khanh Nguyen, M.d, M.D
Internal Medicine — Payments: $10,549
Internal Medicine $10,549
Jack Rutkowski, Md, MD
Internal Medicine — Payments: $10,425
Internal Medicine $10,425
Pamela Maben, Md, MD
Internal Medicine — Payments: $8,279
Internal Medicine $8,279